Jens Kuhn
Concepts (839)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Viruses | 48 | 2025 | 165 | 14.550 |
Why?
| | Genome, Viral | 82 | 2026 | 218 | 14.240 |
Why?
| | RNA Viruses | 33 | 2025 | 76 | 13.120 |
Why?
| | Ebolavirus | 55 | 2026 | 89 | 10.530 |
Why?
| | Hemorrhagic Fever, Ebola | 44 | 2026 | 81 | 8.220 |
Why?
| | Phylogeny | 87 | 2025 | 1016 | 7.860 |
Why?
| | Filoviridae | 22 | 2023 | 27 | 6.860 |
Why?
| | Terminology as Topic | 30 | 2025 | 255 | 5.380 |
Why?
| | Mononegavirales | 10 | 2022 | 10 | 5.110 |
Why?
| | Deep Brain Stimulation | 25 | 2025 | 212 | 4.710 |
Why?
| | Classification | 20 | 2025 | 43 | 4.070 |
Why?
| | Virus Replication | 42 | 2026 | 529 | 4.020 |
Why?
| | Arterivirus | 15 | 2024 | 18 | 3.680 |
Why?
| | Tourette Syndrome | 11 | 2025 | 27 | 3.440 |
Why?
| | RNA, Viral | 32 | 2024 | 688 | 3.390 |
Why?
| | Marburgvirus | 11 | 2024 | 21 | 2.990 |
Why?
| | Virion | 22 | 2025 | 111 | 2.820 |
Why?
| | Arenaviridae | 10 | 2024 | 12 | 2.790 |
Why?
| | Antiviral Agents | 17 | 2024 | 767 | 2.580 |
Why?
| | Arthropods | 4 | 2024 | 16 | 2.520 |
Why?
| | Viral Proteins | 21 | 2025 | 355 | 2.400 |
Why?
| | Animals | 166 | 2026 | 38058 | 2.360 |
Why?
| | Open Reading Frames | 10 | 2024 | 132 | 2.290 |
Why?
| | Hemorrhagic Fevers, Viral | 9 | 2022 | 16 | 2.240 |
Why?
| | Virus Internalization | 18 | 2022 | 65 | 2.140 |
Why?
| | Arterivirus Infections | 9 | 2019 | 10 | 2.120 |
Why?
| | Virology | 12 | 2025 | 36 | 2.080 |
Why?
| | Nucleoproteins | 10 | 2024 | 38 | 2.050 |
Why?
| | Obsessive-Compulsive Disorder | 8 | 2022 | 58 | 2.010 |
Why?
| | Host-Pathogen Interactions | 17 | 2026 | 371 | 2.000 |
Why?
| | Flaviviridae | 4 | 2025 | 10 | 1.970 |
Why?
| | Ebola Vaccines | 9 | 2026 | 13 | 1.940 |
Why?
| | Arenaviridae Infections | 9 | 2024 | 17 | 1.910 |
Why?
| | Filoviridae Infections | 5 | 2019 | 8 | 1.810 |
Why?
| | Rhabdoviridae | 4 | 2024 | 4 | 1.770 |
Why?
| | Viroids | 3 | 2024 | 6 | 1.720 |
Why?
| | Receptors, Virus | 11 | 2015 | 96 | 1.680 |
Why?
| | Antibodies, Viral | 17 | 2026 | 672 | 1.610 |
Why?
| | Bunyaviridae | 4 | 2024 | 4 | 1.590 |
Why?
| | DNA Viruses | 9 | 2025 | 23 | 1.590 |
Why?
| | Viral Vaccines | 9 | 2020 | 107 | 1.540 |
Why?
| | Monkey Diseases | 5 | 2020 | 25 | 1.510 |
Why?
| | Hemorrhagic Fever Virus, Crimean-Congo | 7 | 2023 | 12 | 1.450 |
Why?
| | Hemorrhagic Fever, Crimean | 6 | 2023 | 10 | 1.360 |
Why?
| | Wasps | 6 | 2024 | 23 | 1.320 |
Why?
| | Humans | 198 | 2026 | 144759 | 1.300 |
Why?
| | Evolution, Molecular | 13 | 2025 | 514 | 1.290 |
Why?
| | Containment of Biohazards | 8 | 2025 | 21 | 1.280 |
Why?
| | Disease Outbreaks | 20 | 2021 | 422 | 1.190 |
Why?
| | Chiroptera | 7 | 2021 | 61 | 1.160 |
Why?
| | Green Fluorescent Proteins | 3 | 2023 | 405 | 1.150 |
Why?
| | Nipah Virus | 3 | 2025 | 3 | 1.110 |
Why?
| | Lassa virus | 7 | 2023 | 9 | 1.100 |
Why?
| | Genetic Variation | 13 | 2020 | 983 | 1.090 |
Why?
| | Henipavirus Infections | 2 | 2025 | 2 | 1.090 |
Why?
| | Vero Cells | 18 | 2023 | 84 | 1.080 |
Why?
| | Viral Envelope Proteins | 12 | 2025 | 98 | 1.030 |
Why?
| | Organoids | 2 | 2026 | 141 | 1.020 |
Why?
| | Brain | 15 | 2026 | 2933 | 1.020 |
Why?
| | Basal Nucleus of Meynert | 3 | 2017 | 4 | 1.010 |
Why?
| | Connectome | 3 | 2024 | 95 | 1.010 |
Why?
| | Delay Discounting | 3 | 2023 | 29 | 1.010 |
Why?
| | Drug Evaluation, Preclinical | 5 | 2020 | 194 | 0.980 |
Why?
| | Macaca mulatta | 12 | 2025 | 191 | 0.980 |
Why?
| | RNA Virus Infections | 5 | 2018 | 20 | 0.970 |
Why?
| | Monkeypox virus | 4 | 2025 | 23 | 0.960 |
Why?
| | Animal Use Alternatives | 1 | 2025 | 1 | 0.940 |
Why?
| | Communicable Diseases, Emerging | 4 | 2022 | 38 | 0.930 |
Why?
| | Coronavirus Infections | 8 | 2020 | 378 | 0.890 |
Why?
| | Pyrimidine Nucleosides | 2 | 2022 | 3 | 0.890 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2025 | 63 | 0.880 |
Why?
| | Glycoproteins | 13 | 2025 | 355 | 0.870 |
Why?
| | Nairovirus | 3 | 2024 | 3 | 0.870 |
Why?
| | Primates | 12 | 2023 | 132 | 0.850 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2025 | 78 | 0.850 |
Why?
| | Archaeal Viruses | 4 | 2025 | 12 | 0.840 |
Why?
| | Genomics | 13 | 2024 | 834 | 0.840 |
Why?
| | Helper Viruses | 1 | 2024 | 3 | 0.830 |
Why?
| | DNA, Complementary | 4 | 2021 | 276 | 0.820 |
Why?
| | Recombination, Genetic | 2 | 2024 | 205 | 0.820 |
Why?
| | Viral Core Proteins | 2 | 2020 | 22 | 0.810 |
Why?
| | Primate Diseases | 4 | 2018 | 8 | 0.810 |
Why?
| | Antibodies, Monoclonal | 7 | 2025 | 1519 | 0.800 |
Why?
| | Antigens, CD | 7 | 2023 | 555 | 0.790 |
Why?
| | Flavivirus | 1 | 2023 | 19 | 0.790 |
Why?
| | Cell Line | 21 | 2025 | 2882 | 0.780 |
Why?
| | Polydnaviridae | 1 | 2023 | 1 | 0.780 |
Why?
| | Rhabdoviridae Infections | 2 | 2020 | 2 | 0.770 |
Why?
| | Arteriviridae | 4 | 2018 | 4 | 0.760 |
Why?
| | Mammals | 6 | 2024 | 293 | 0.760 |
Why?
| | Biomedical Research | 5 | 2014 | 710 | 0.750 |
Why?
| | Thalamus | 5 | 2025 | 125 | 0.750 |
Why?
| | Databases, Nucleic Acid | 3 | 2023 | 39 | 0.750 |
Why?
| | Disease Reservoirs | 4 | 2017 | 25 | 0.740 |
Why?
| | Arenaviruses, New World | 6 | 2013 | 9 | 0.740 |
Why?
| | Antibodies, Neutralizing | 9 | 2025 | 340 | 0.720 |
Why?
| | Frontal Lobe | 3 | 2025 | 160 | 0.700 |
Why?
| | Alzheimer Disease | 3 | 2017 | 621 | 0.690 |
Why?
| | Clinical Deterioration | 1 | 2021 | 9 | 0.680 |
Why?
| | Virus Diseases | 3 | 2020 | 216 | 0.670 |
Why?
| | Macaca | 6 | 2025 | 65 | 0.670 |
Why?
| | Pan troglodytes | 2 | 2021 | 63 | 0.670 |
Why?
| | Lassa Fever | 4 | 2023 | 6 | 0.670 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 3 | 2016 | 11 | 0.670 |
Why?
| | Post-Exposure Prophylaxis | 2 | 2020 | 13 | 0.660 |
Why?
| | Marburg Virus Disease | 4 | 2023 | 11 | 0.660 |
Why?
| | Parkinson Disease | 4 | 2022 | 600 | 0.660 |
Why?
| | Picornaviridae | 1 | 2020 | 18 | 0.660 |
Why?
| | Impulsive Behavior | 2 | 2022 | 146 | 0.650 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 3 | 2023 | 65 | 0.650 |
Why?
| | Neutralization Tests | 3 | 2019 | 76 | 0.640 |
Why?
| | Symbiosis | 2 | 2024 | 81 | 0.630 |
Why?
| | Picornaviridae Infections | 1 | 2020 | 50 | 0.630 |
Why?
| | Biological Evolution | 7 | 2024 | 488 | 0.630 |
Why?
| | International Cooperation | 3 | 2021 | 198 | 0.630 |
Why?
| | Receptors, Transferrin | 4 | 2013 | 28 | 0.620 |
Why?
| | World Health Organization | 2 | 2021 | 105 | 0.620 |
Why?
| | Bornaviridae | 2 | 2021 | 2 | 0.620 |
Why?
| | Membrane Glycoproteins | 7 | 2015 | 496 | 0.600 |
Why?
| | Metagenomics | 8 | 2024 | 181 | 0.590 |
Why?
| | Staining and Labeling | 2 | 2020 | 151 | 0.590 |
Why?
| | Biodiversity | 2 | 2022 | 426 | 0.580 |
Why?
| | Luminescent Agents | 1 | 2018 | 8 | 0.580 |
Why?
| | Receptors, Cell Surface | 4 | 2023 | 377 | 0.580 |
Why?
| | Antipsychotic Agents | 1 | 2021 | 213 | 0.570 |
Why?
| | Corpus Striatum | 1 | 2020 | 179 | 0.560 |
Why?
| | Genes, Reporter | 2 | 2018 | 275 | 0.560 |
Why?
| | Reverse Transcription | 1 | 2018 | 20 | 0.560 |
Why?
| | Sequence Analysis, DNA | 13 | 2017 | 824 | 0.550 |
Why?
| | Macaca fascicularis | 3 | 2021 | 71 | 0.550 |
Why?
| | Hantavirus Pulmonary Syndrome | 3 | 2023 | 5 | 0.540 |
Why?
| | Evoked Potentials | 2 | 2018 | 128 | 0.540 |
Why?
| | Influenza A virus | 4 | 2025 | 113 | 0.540 |
Why?
| | Host Specificity | 7 | 2025 | 34 | 0.540 |
Why?
| | Archaea | 3 | 2025 | 86 | 0.530 |
Why?
| | Amino Acid Sequence | 16 | 2020 | 2155 | 0.530 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4557 | 0.530 |
Why?
| | Nucleus Accumbens | 9 | 2023 | 132 | 0.520 |
Why?
| | High-Throughput Nucleotide Sequencing | 8 | 2020 | 549 | 0.510 |
Why?
| | Reaction Time | 2 | 2018 | 438 | 0.510 |
Why?
| | Bird Diseases | 2 | 2016 | 16 | 0.510 |
Why?
| | Societies, Scientific | 2 | 2017 | 49 | 0.490 |
Why?
| | Endocytosis | 2 | 2014 | 168 | 0.490 |
Why?
| | Reverse Genetics | 4 | 2021 | 7 | 0.490 |
Why?
| | Neglected Diseases | 1 | 2016 | 5 | 0.490 |
Why?
| | Borna Disease | 2 | 2021 | 2 | 0.490 |
Why?
| | Male | 55 | 2026 | 72315 | 0.480 |
Why?
| | Colobus | 1 | 2016 | 3 | 0.480 |
Why?
| | Retroviridae | 4 | 2025 | 101 | 0.480 |
Why?
| | Cognitive Dysfunction | 1 | 2022 | 461 | 0.480 |
Why?
| | Dogs | 2 | 2015 | 437 | 0.470 |
Why?
| | Dipeptidyl Peptidase 4 | 2 | 2016 | 15 | 0.470 |
Why?
| | HEK293 Cells | 11 | 2025 | 744 | 0.460 |
Why?
| | Hospitals, Psychiatric | 1 | 2015 | 27 | 0.460 |
Why?
| | Laboratories | 4 | 2016 | 109 | 0.460 |
Why?
| | Animal Assisted Therapy | 1 | 2015 | 13 | 0.460 |
Why?
| | Africa | 8 | 2021 | 116 | 0.460 |
Why?
| | Psychomotor Performance | 1 | 2018 | 328 | 0.450 |
Why?
| | Hospitals, University | 1 | 2015 | 176 | 0.450 |
Why?
| | Ticks | 5 | 2023 | 29 | 0.440 |
Why?
| | Communicable Diseases | 2 | 2014 | 163 | 0.440 |
Why?
| | Insecta | 3 | 2024 | 74 | 0.440 |
Why?
| | Reflex, Startle | 2 | 2020 | 76 | 0.430 |
Why?
| | Female | 52 | 2026 | 78271 | 0.430 |
Why?
| | Nematoda | 2 | 2017 | 12 | 0.430 |
Why?
| | Tic Disorders | 1 | 2014 | 9 | 0.420 |
Why?
| | Asymptomatic Infections | 4 | 2018 | 37 | 0.420 |
Why?
| | Depressive Disorder | 2 | 2015 | 387 | 0.420 |
Why?
| | Plant Viruses | 3 | 2025 | 12 | 0.410 |
Why?
| | Reassortant Viruses | 1 | 2013 | 8 | 0.410 |
Why?
| | Molecular Sequence Data | 16 | 2015 | 2930 | 0.400 |
Why?
| | Virus Release | 5 | 2020 | 8 | 0.400 |
Why?
| | Communicable Disease Control | 1 | 2014 | 86 | 0.400 |
Why?
| | Cluster Analysis | 9 | 2019 | 521 | 0.400 |
Why?
| | Aerosols | 5 | 2026 | 186 | 0.400 |
Why?
| | Cricetinae | 6 | 2026 | 303 | 0.390 |
Why?
| | Mesocricetus | 5 | 2026 | 46 | 0.390 |
Why?
| | Viral Load | 6 | 2020 | 526 | 0.390 |
Why?
| | Positron Emission Tomography Computed Tomography | 2 | 2026 | 117 | 0.380 |
Why?
| | Animals, Laboratory | 1 | 2013 | 21 | 0.380 |
Why?
| | Magnetic Resonance Imaging | 8 | 2025 | 3863 | 0.370 |
Why?
| | Treatment Outcome | 13 | 2023 | 11679 | 0.370 |
Why?
| | Infectious bronchitis virus | 3 | 2017 | 3 | 0.370 |
Why?
| | Zoonoses | 4 | 2022 | 36 | 0.360 |
Why?
| | Viruses, Unclassified | 2 | 2022 | 4 | 0.360 |
Why?
| | Suicide, Attempted | 2 | 2026 | 422 | 0.350 |
Why?
| | Bioterrorism | 1 | 2011 | 31 | 0.350 |
Why?
| | Capsid Proteins | 4 | 2025 | 95 | 0.350 |
Why?
| | Safety | 4 | 2016 | 356 | 0.340 |
Why?
| | Peptidyl-Dipeptidase A | 4 | 2007 | 56 | 0.340 |
Why?
| | Autistic Disorder | 1 | 2014 | 211 | 0.340 |
Why?
| | Occupational Health | 1 | 2014 | 209 | 0.340 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2011 | 41 | 0.330 |
Why?
| | Specimen Handling | 3 | 2025 | 186 | 0.330 |
Why?
| | Immunoglobulin G | 4 | 2026 | 893 | 0.330 |
Why?
| | Sequence Alignment | 7 | 2020 | 366 | 0.320 |
Why?
| | Internal Capsule | 5 | 2022 | 8 | 0.320 |
Why?
| | Viral Tropism | 3 | 2026 | 36 | 0.320 |
Why?
| | Bacteriophages | 3 | 2023 | 111 | 0.320 |
Why?
| | Animals, Wild | 4 | 2020 | 61 | 0.320 |
Why?
| | Neural Pathways | 3 | 2025 | 311 | 0.320 |
Why?
| | Neuroimaging | 2 | 2025 | 289 | 0.320 |
Why?
| | Plasmids | 2 | 2021 | 379 | 0.310 |
Why?
| | Guinea Pigs | 8 | 2026 | 159 | 0.310 |
Why?
| | Beta Rhythm | 2 | 2024 | 33 | 0.310 |
Why?
| | Suicidal Ideation | 2 | 2026 | 577 | 0.310 |
Why?
| | Nervous System Diseases | 2 | 2010 | 284 | 0.300 |
Why?
| | Adult | 26 | 2026 | 40449 | 0.300 |
Why?
| | Sequence Homology | 4 | 2017 | 43 | 0.300 |
Why?
| | Animal Diseases | 2 | 2022 | 8 | 0.300 |
Why?
| | Genotype | 6 | 2022 | 1833 | 0.290 |
Why?
| | Virulence | 4 | 2024 | 278 | 0.290 |
Why?
| | RNA | 5 | 2023 | 940 | 0.290 |
Why?
| | Young Adult | 12 | 2026 | 14105 | 0.290 |
Why?
| | Pandemics | 5 | 2021 | 1694 | 0.290 |
Why?
| | Mental Disorders | 2 | 2026 | 1168 | 0.290 |
Why?
| | Neuropsychological Tests | 4 | 2021 | 1134 | 0.280 |
Why?
| | Electroencephalography | 6 | 2025 | 532 | 0.280 |
Why?
| | Mice | 18 | 2025 | 18339 | 0.280 |
Why?
| | Antidepressive Agents | 2 | 2021 | 248 | 0.280 |
Why?
| | Pick Disease of the Brain | 1 | 2007 | 4 | 0.270 |
Why?
| | Africa, Western | 4 | 2020 | 21 | 0.260 |
Why?
| | Bayes Theorem | 4 | 2023 | 433 | 0.260 |
Why?
| | Tics | 2 | 2024 | 5 | 0.250 |
Why?
| | Positron-Emission Tomography | 3 | 2022 | 323 | 0.250 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2017 | 541 | 0.250 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2018 | 396 | 0.250 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 4 | 2014 | 25 | 0.250 |
Why?
| | Depressive Disorder, Treatment-Resistant | 2 | 2017 | 13 | 0.250 |
Why?
| | Middle Aged | 20 | 2026 | 35875 | 0.250 |
Why?
| | Virus Cultivation | 2 | 2018 | 31 | 0.240 |
Why?
| | Whole Genome Sequencing | 4 | 2025 | 182 | 0.240 |
Why?
| | Subthalamic Nucleus | 3 | 2020 | 83 | 0.240 |
Why?
| | Aotidae | 1 | 2026 | 10 | 0.240 |
Why?
| | Gyrus Cinguli | 2 | 2017 | 96 | 0.240 |
Why?
| | DNA, Viral | 4 | 2025 | 358 | 0.240 |
Why?
| | ADP-Ribosylation | 1 | 2025 | 1 | 0.240 |
Why?
| | Viremia | 2 | 2025 | 158 | 0.240 |
Why?
| | Rumination, Cognitive | 1 | 2026 | 11 | 0.240 |
Why?
| | Toxicity Tests | 2 | 2016 | 38 | 0.240 |
Why?
| | Replicon | 1 | 2025 | 15 | 0.240 |
Why?
| | Metacognition | 1 | 2026 | 17 | 0.230 |
Why?
| | Species Specificity | 2 | 2017 | 574 | 0.230 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2026 | 32 | 0.230 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2026 | 156 | 0.230 |
Why?
| | Receptors, CXCR4 | 1 | 2026 | 91 | 0.230 |
Why?
| | RNA Helicases | 1 | 2025 | 31 | 0.230 |
Why?
| | Nucleocapsid Proteins | 3 | 2020 | 28 | 0.230 |
Why?
| | Germany | 4 | 2020 | 138 | 0.230 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2025 | 53 | 0.220 |
Why?
| | Genes, Viral | 3 | 2020 | 90 | 0.220 |
Why?
| | Virus Inactivation | 1 | 2025 | 13 | 0.220 |
Why?
| | Nerve Net | 4 | 2025 | 285 | 0.220 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 384 | 0.220 |
Why?
| | Dengue Virus | 1 | 2025 | 58 | 0.220 |
Why?
| | Schizophrenia | 2 | 2019 | 446 | 0.220 |
Why?
| | Respiratory System | 1 | 2026 | 149 | 0.220 |
Why?
| | Clinical Laboratory Techniques | 3 | 2020 | 96 | 0.220 |
Why?
| | Immunity, Humoral | 1 | 2025 | 120 | 0.210 |
Why?
| | Fungal Viruses | 1 | 2024 | 1 | 0.210 |
Why?
| | Liberia | 6 | 2025 | 15 | 0.210 |
Why?
| | Vaccination | 6 | 2026 | 1423 | 0.210 |
Why?
| | Poxviridae | 1 | 2024 | 3 | 0.210 |
Why?
| | Orthopoxvirus | 1 | 2024 | 4 | 0.210 |
Why?
| | Tenuivirus | 1 | 2024 | 1 | 0.210 |
Why?
| | Hemiptera | 1 | 2024 | 4 | 0.210 |
Why?
| | Immunization, Secondary | 1 | 2024 | 91 | 0.210 |
Why?
| | Drug Discovery | 3 | 2015 | 155 | 0.210 |
Why?
| | Ficus | 1 | 2024 | 2 | 0.210 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 170 | 0.210 |
Why?
| | History, 20th Century | 5 | 2020 | 325 | 0.210 |
Why?
| | One Health | 2 | 2021 | 10 | 0.210 |
Why?
| | Rodentia | 2 | 2021 | 61 | 0.210 |
Why?
| | Proof of Concept Study | 2 | 2021 | 85 | 0.200 |
Why?
| | Oryza | 1 | 2024 | 32 | 0.200 |
Why?
| | Lactate dehydrogenase-elevating virus | 1 | 2023 | 1 | 0.200 |
Why?
| | Ectopic Gene Expression | 1 | 2023 | 5 | 0.200 |
Why?
| | Crustacea | 1 | 2023 | 5 | 0.200 |
Why?
| | Base Sequence | 6 | 2017 | 2190 | 0.200 |
Why?
| | Models, Molecular | 9 | 2024 | 1618 | 0.200 |
Why?
| | Immunohistochemistry | 4 | 2020 | 1716 | 0.200 |
Why?
| | DNA Transposable Elements | 1 | 2024 | 122 | 0.200 |
Why?
| | Uganda | 3 | 2020 | 93 | 0.200 |
Why?
| | Dementia | 1 | 2007 | 303 | 0.200 |
Why?
| | Quality of Life | 6 | 2023 | 3185 | 0.200 |
Why?
| | Public Health Surveillance | 2 | 2021 | 83 | 0.190 |
Why?
| | Drug Design | 1 | 2024 | 173 | 0.190 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2020 | 94 | 0.190 |
Why?
| | Disinfectants | 1 | 2023 | 46 | 0.190 |
Why?
| | Electrodes, Implanted | 2 | 2020 | 115 | 0.190 |
Why?
| | Adolescent | 10 | 2026 | 22428 | 0.190 |
Why?
| | Biological Products | 2 | 2020 | 252 | 0.190 |
Why?
| | Frameshifting, Ribosomal | 2 | 2019 | 9 | 0.190 |
Why?
| | Fungi | 1 | 2024 | 161 | 0.190 |
Why?
| | Vaccines, Attenuated | 2 | 2020 | 129 | 0.190 |
Why?
| | Cytopathogenic Effect, Viral | 2 | 2020 | 16 | 0.190 |
Why?
| | Plankton | 1 | 2022 | 7 | 0.190 |
Why?
| | Democratic Republic of the Congo | 3 | 2019 | 33 | 0.180 |
Why?
| | Cell Culture Techniques | 2 | 2023 | 375 | 0.180 |
Why?
| | Seawater | 1 | 2022 | 31 | 0.180 |
Why?
| | Virus Physiological Phenomena | 2 | 2020 | 8 | 0.180 |
Why?
| | Viral Plaque Assay | 2 | 2025 | 29 | 0.180 |
Why?
| | Antigens, Differentiation | 2 | 2013 | 77 | 0.180 |
Why?
| | Cowpox virus | 1 | 2021 | 2 | 0.180 |
Why?
| | Fish Diseases | 1 | 2021 | 17 | 0.180 |
Why?
| | Ribavirin | 2 | 2020 | 80 | 0.180 |
Why?
| | Hepacivirus | 1 | 2023 | 243 | 0.180 |
Why?
| | HIV-1 | 3 | 2026 | 896 | 0.170 |
Why?
| | Borna disease virus | 1 | 2021 | 1 | 0.170 |
Why?
| | Smallpox | 1 | 2021 | 10 | 0.170 |
Why?
| | Dicistroviridae | 1 | 2021 | 7 | 0.170 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2019 | 36 | 0.170 |
Why?
| | Sarcina | 1 | 2021 | 1 | 0.170 |
Why?
| | Uveitis | 1 | 2022 | 148 | 0.170 |
Why?
| | Proteome | 2 | 2018 | 518 | 0.170 |
Why?
| | Fluvoxamine | 1 | 2021 | 16 | 0.170 |
Why?
| | Papio | 2 | 2018 | 85 | 0.170 |
Why?
| | Ape Diseases | 1 | 2021 | 7 | 0.170 |
Why?
| | Rubella virus | 1 | 2020 | 7 | 0.170 |
Why?
| | Plant Diseases | 2 | 2024 | 44 | 0.170 |
Why?
| | RNA, Small Interfering | 4 | 2016 | 635 | 0.170 |
Why?
| | Addiction Medicine | 1 | 2021 | 14 | 0.170 |
Why?
| | Phlebovirus | 1 | 2020 | 6 | 0.160 |
Why?
| | Anti-Infective Agents | 1 | 2023 | 242 | 0.160 |
Why?
| | Immunotoxins | 1 | 2021 | 55 | 0.160 |
Why?
| | Laboratory Infection | 1 | 2020 | 1 | 0.160 |
Why?
| | Reward | 2 | 2020 | 247 | 0.160 |
Why?
| | Bunyaviridae Infections | 1 | 2020 | 15 | 0.160 |
Why?
| | DNA Replication | 2 | 2020 | 251 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 286 | 0.160 |
Why?
| | DNA, Circular | 1 | 2020 | 15 | 0.160 |
Why?
| | Clinical Trials as Topic | 2 | 2016 | 1053 | 0.160 |
Why?
| | Carrier State | 2 | 2020 | 79 | 0.160 |
Why?
| | Mutation | 9 | 2025 | 4089 | 0.160 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2020 | 27 | 0.160 |
Why?
| | RNA Polymerase II | 1 | 2024 | 351 | 0.160 |
Why?
| | Myocarditis | 1 | 2021 | 102 | 0.160 |
Why?
| | Hominidae | 1 | 2021 | 87 | 0.160 |
Why?
| | Semen | 2 | 2021 | 23 | 0.160 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2021 | 69 | 0.160 |
Why?
| | Caudovirales | 1 | 2020 | 1 | 0.160 |
Why?
| | Cell Line, Tumor | 4 | 2022 | 3540 | 0.160 |
Why?
| | DNA, Intergenic | 1 | 2020 | 29 | 0.160 |
Why?
| | Eukaryota | 3 | 2025 | 60 | 0.160 |
Why?
| | Child Abuse | 1 | 2026 | 551 | 0.160 |
Why?
| | Emphysema | 1 | 2021 | 100 | 0.160 |
Why?
| | Arenavirus | 2 | 2020 | 2 | 0.160 |
Why?
| | Liver Diseases | 1 | 2023 | 304 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 983 | 0.150 |
Why?
| | Sequence Analysis, RNA | 3 | 2018 | 442 | 0.150 |
Why?
| | Gastritis | 1 | 2021 | 115 | 0.150 |
Why?
| | Porcine respiratory and reproductive syndrome virus | 1 | 2019 | 1 | 0.150 |
Why?
| | In Situ Hybridization | 2 | 2020 | 319 | 0.150 |
Why?
| | Respiration | 2 | 2018 | 206 | 0.150 |
Why?
| | Influenza, Human | 1 | 2025 | 616 | 0.150 |
Why?
| | Databases, Pharmaceutical | 1 | 2019 | 5 | 0.150 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 370 | 0.150 |
Why?
| | Molecular Structure | 1 | 2020 | 499 | 0.150 |
Why?
| | A549 Cells | 4 | 2020 | 75 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 2027 | 0.150 |
Why?
| | Internationality | 3 | 2017 | 156 | 0.150 |
Why?
| | Drug Repositioning | 1 | 2019 | 41 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 5 | 2025 | 851 | 0.150 |
Why?
| | DNA, Single-Stranded | 1 | 2020 | 119 | 0.150 |
Why?
| | Neuronavigation | 1 | 2019 | 8 | 0.150 |
Why?
| | Guinea | 2 | 2018 | 3 | 0.150 |
Why?
| | Ixodidae | 1 | 2019 | 7 | 0.150 |
Why?
| | Gene Rearrangement | 1 | 2020 | 155 | 0.150 |
Why?
| | Follow-Up Studies | 6 | 2020 | 5408 | 0.150 |
Why?
| | Phage Therapy | 1 | 2019 | 17 | 0.150 |
Why?
| | Fluorometry | 1 | 2018 | 18 | 0.150 |
Why?
| | Tiletamine | 1 | 2018 | 2 | 0.140 |
Why?
| | Zolazepam | 1 | 2018 | 2 | 0.140 |
Why?
| | Shrews | 1 | 2018 | 3 | 0.140 |
Why?
| | Cerebral Cortex | 2 | 2024 | 464 | 0.140 |
Why?
| | Hepadnaviridae | 1 | 2018 | 1 | 0.140 |
Why?
| | Caulimoviridae | 1 | 2018 | 1 | 0.140 |
Why?
| | Immobilization | 1 | 2018 | 53 | 0.140 |
Why?
| | Cell Survival | 1 | 2022 | 1098 | 0.140 |
Why?
| | Mononegavirales Infections | 1 | 2018 | 1 | 0.140 |
Why?
| | Midazolam | 1 | 2018 | 72 | 0.140 |
Why?
| | Schizophrenic Psychology | 1 | 2018 | 97 | 0.140 |
Why?
| | Time Factors | 5 | 2026 | 7173 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2020 | 139 | 0.140 |
Why?
| | Spumavirus | 1 | 2018 | 3 | 0.140 |
Why?
| | Models, Neurological | 1 | 2020 | 254 | 0.140 |
Why?
| | Cell Membrane | 2 | 2020 | 706 | 0.140 |
Why?
| | Genomic Instability | 1 | 2018 | 66 | 0.140 |
Why?
| | Boidae | 1 | 2018 | 29 | 0.140 |
Why?
| | Double-Blind Method | 4 | 2026 | 2029 | 0.140 |
Why?
| | Severe Acute Respiratory Syndrome | 3 | 2007 | 19 | 0.140 |
Why?
| | Committee Membership | 3 | 2023 | 5 | 0.140 |
Why?
| | Encephalomyocarditis virus | 1 | 2017 | 1 | 0.140 |
Why?
| | Papio hamadryas | 1 | 2017 | 3 | 0.140 |
Why?
| | Cardiovirus Infections | 1 | 2017 | 3 | 0.140 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 51 | 0.130 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2018 | 25 | 0.130 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 56 | 0.130 |
Why?
| | Retroviridae Infections | 1 | 2018 | 47 | 0.130 |
Why?
| | Motivational Interviewing | 1 | 2019 | 121 | 0.130 |
Why?
| | Testis | 1 | 2018 | 163 | 0.130 |
Why?
| | Amino Acids | 2 | 2020 | 521 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 2 | 2025 | 477 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2021 | 582 | 0.130 |
Why?
| | Biotechnology | 1 | 2018 | 46 | 0.130 |
Why?
| | MicroRNAs | 1 | 2024 | 701 | 0.130 |
Why?
| | Software Design | 1 | 2017 | 25 | 0.130 |
Why?
| | Gene Order | 1 | 2017 | 27 | 0.130 |
Why?
| | Maryland | 2 | 2014 | 66 | 0.130 |
Why?
| | Acoustic Stimulation | 2 | 2020 | 333 | 0.130 |
Why?
| | Poultry Diseases | 1 | 2017 | 13 | 0.130 |
Why?
| | Outpatients | 1 | 2021 | 442 | 0.130 |
Why?
| | Dopamine | 1 | 2020 | 283 | 0.130 |
Why?
| | Diptera | 1 | 2017 | 31 | 0.130 |
Why?
| | Spike Glycoprotein, Coronavirus | 5 | 2017 | 130 | 0.130 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 824 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 4 | 2023 | 2730 | 0.120 |
Why?
| | Birds | 2 | 2017 | 92 | 0.120 |
Why?
| | Encephalitis Virus, Venezuelan Equine | 1 | 2016 | 6 | 0.120 |
Why?
| | Zika Virus | 1 | 2018 | 132 | 0.120 |
Why?
| | Flaviviridae Infections | 1 | 2016 | 2 | 0.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 427 | 0.120 |
Why?
| | Protective Clothing | 1 | 2016 | 15 | 0.120 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.120 |
Why?
| | Lentivirus Infections | 1 | 2016 | 9 | 0.120 |
Why?
| | Gene Regulatory Networks | 1 | 2019 | 318 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2020 | 780 | 0.120 |
Why?
| | Plethysmography | 1 | 2016 | 108 | 0.120 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2016 | 39 | 0.120 |
Why?
| | Polymerase Chain Reaction | 2 | 2017 | 1054 | 0.120 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2016 | 25 | 0.120 |
Why?
| | Viral Nonstructural Proteins | 3 | 2025 | 67 | 0.120 |
Why?
| | Functional Laterality | 1 | 2017 | 241 | 0.120 |
Why?
| | Alphavirus | 1 | 2016 | 22 | 0.120 |
Why?
| | Chromosomes, Mammalian | 1 | 2016 | 28 | 0.120 |
Why?
| | Macrophages | 4 | 2024 | 1511 | 0.120 |
Why?
| | Selection, Genetic | 2 | 2017 | 256 | 0.120 |
Why?
| | Hemorrhage | 1 | 2021 | 809 | 0.120 |
Why?
| | Extracellular Vesicles | 1 | 2018 | 171 | 0.120 |
Why?
| | Virus Attachment | 1 | 2015 | 18 | 0.120 |
Why?
| | Immunoassay | 1 | 2016 | 109 | 0.120 |
Why?
| | Satellite Viruses | 1 | 2015 | 1 | 0.120 |
Why?
| | Orthobunyavirus | 1 | 2015 | 8 | 0.120 |
Why?
| | Alcoholism | 1 | 2023 | 817 | 0.120 |
Why?
| | Zika Virus Infection | 1 | 2018 | 168 | 0.120 |
Why?
| | Heat-Shock Proteins | 1 | 2016 | 138 | 0.120 |
Why?
| | Alphavirus Infections | 1 | 2016 | 45 | 0.120 |
Why?
| | Protein Binding | 7 | 2018 | 2273 | 0.120 |
Why?
| | Cell Cycle | 1 | 2018 | 596 | 0.110 |
Why?
| | Italy | 2 | 2025 | 113 | 0.110 |
Why?
| | Learning | 1 | 2020 | 452 | 0.110 |
Why?
| | Immunization, Passive | 1 | 2015 | 87 | 0.110 |
Why?
| | Rabbits | 3 | 2020 | 648 | 0.110 |
Why?
| | Plants | 3 | 2025 | 226 | 0.110 |
Why?
| | Skin | 1 | 2020 | 755 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2020 | 588 | 0.110 |
Why?
| | Lung | 3 | 2026 | 4109 | 0.110 |
Why?
| | Carboxypeptidases | 2 | 2005 | 12 | 0.110 |
Why?
| | Immune Evasion | 1 | 2015 | 64 | 0.110 |
Why?
| | Epitopes | 3 | 2025 | 485 | 0.110 |
Why?
| | Cysteine Proteases | 1 | 2014 | 8 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2015 | 83 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1966 | 0.110 |
Why?
| | DNA | 1 | 2021 | 1463 | 0.110 |
Why?
| | Physician-Patient Relations | 1 | 2019 | 585 | 0.110 |
Why?
| | RNA Interference | 2 | 2016 | 476 | 0.110 |
Why?
| | Computational Biology | 4 | 2025 | 680 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2018 | 437 | 0.110 |
Why?
| | Compulsive Behavior | 1 | 2014 | 6 | 0.110 |
Why?
| | Veterinary Medicine | 1 | 2014 | 9 | 0.110 |
Why?
| | Animal Experimentation | 1 | 2014 | 8 | 0.110 |
Why?
| | Asia | 3 | 2023 | 70 | 0.110 |
Why?
| | Substance-Related Disorders | 2 | 2021 | 1094 | 0.100 |
Why?
| | Adaptation, Biological | 1 | 2014 | 52 | 0.100 |
Why?
| | Aged | 8 | 2021 | 25913 | 0.100 |
Why?
| | Animals, Zoo | 3 | 2020 | 15 | 0.100 |
Why?
| | Dopamine Agonists | 1 | 2014 | 42 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 600 | 0.100 |
Why?
| | Endosomes | 2 | 2014 | 140 | 0.100 |
Why?
| | Optical Imaging | 1 | 2014 | 64 | 0.100 |
Why?
| | Forecasting | 1 | 2015 | 391 | 0.100 |
Why?
| | Habituation, Psychophysiologic | 1 | 2014 | 58 | 0.100 |
Why?
| | Comorbidity | 2 | 2020 | 1658 | 0.100 |
Why?
| | Clathrin-Coated Vesicles | 1 | 2013 | 5 | 0.100 |
Why?
| | Rift Valley fever virus | 1 | 2013 | 3 | 0.100 |
Why?
| | Hepatocytes | 1 | 2014 | 223 | 0.100 |
Why?
| | Molecular Epidemiology | 3 | 2020 | 73 | 0.100 |
Why?
| | Clathrin | 1 | 2013 | 26 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2025 | 1166 | 0.100 |
Why?
| | Nucleic Acid Conformation | 1 | 2016 | 726 | 0.100 |
Why?
| | Psychometrics | 1 | 2017 | 734 | 0.100 |
Why?
| | DNA Mutational Analysis | 4 | 2017 | 406 | 0.100 |
Why?
| | Tissue Culture Techniques | 1 | 2013 | 83 | 0.100 |
Why?
| | Inhalation Exposure | 1 | 2014 | 115 | 0.100 |
Why?
| | Disease Susceptibility | 1 | 2014 | 348 | 0.090 |
Why?
| | Perception | 1 | 2016 | 377 | 0.090 |
Why?
| | Survivors | 3 | 2022 | 520 | 0.090 |
Why?
| | Empathy | 1 | 2015 | 182 | 0.090 |
Why?
| | United States | 6 | 2024 | 15966 | 0.090 |
Why?
| | Neural Inhibition | 1 | 2014 | 178 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 380 | 0.090 |
Why?
| | Oceans and Seas | 2 | 2022 | 23 | 0.090 |
Why?
| | Virosomes | 1 | 2012 | 2 | 0.090 |
Why?
| | Self Concept | 1 | 2014 | 253 | 0.090 |
Why?
| | Emotions | 2 | 2015 | 578 | 0.090 |
Why?
| | Protein Kinases | 1 | 2014 | 315 | 0.090 |
Why?
| | Diagnostic Errors | 2 | 2017 | 175 | 0.090 |
Why?
| | Cross Reactions | 1 | 2012 | 130 | 0.090 |
Why?
| | Global Health | 2 | 2021 | 401 | 0.090 |
Why?
| | Retrospective Studies | 8 | 2026 | 17066 | 0.090 |
Why?
| | Cell Movement | 1 | 2016 | 965 | 0.090 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 449 | 0.090 |
Why?
| | Liver | 2 | 2018 | 1887 | 0.080 |
Why?
| | Bipolar Disorder | 1 | 2014 | 280 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 675 | 0.080 |
Why?
| | Invertebrates | 2 | 2021 | 24 | 0.080 |
Why?
| | HIV Infections | 1 | 2026 | 3154 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2014 | 737 | 0.080 |
Why?
| | Models, Animal | 2 | 2023 | 392 | 0.080 |
Why?
| | Particle Size | 2 | 2026 | 411 | 0.080 |
Why?
| | Immunity, Innate | 2 | 2026 | 846 | 0.080 |
Why?
| | Cattle | 2 | 2016 | 1000 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2021 | 2145 | 0.080 |
Why?
| | Prevalence | 4 | 2019 | 2834 | 0.070 |
Why?
| | Algorithms | 1 | 2017 | 1837 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 462 | 0.070 |
Why?
| | Viral Fusion Proteins | 1 | 2009 | 21 | 0.070 |
Why?
| | Fibroblasts | 1 | 2014 | 1034 | 0.070 |
Why?
| | Sierra Leone | 2 | 2021 | 3 | 0.070 |
Why?
| | Ceruloplasmin | 1 | 2008 | 9 | 0.070 |
Why?
| | History, 21st Century | 3 | 2017 | 219 | 0.070 |
Why?
| | Sensory Gating | 2 | 2020 | 44 | 0.070 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2008 | 6 | 0.070 |
Why?
| | Protein Structure, Tertiary | 4 | 2014 | 862 | 0.070 |
Why?
| | Up-Regulation | 2 | 2024 | 851 | 0.070 |
Why?
| | Communication | 3 | 2021 | 965 | 0.070 |
Why?
| | Interferons | 2 | 2020 | 188 | 0.070 |
Why?
| | Child | 3 | 2026 | 22633 | 0.070 |
Why?
| | Virus Assembly | 2 | 2020 | 81 | 0.070 |
Why?
| | Binding Sites | 5 | 2011 | 1329 | 0.070 |
Why?
| | Prospective Studies | 2 | 2026 | 7990 | 0.070 |
Why?
| | Rehabilitation, Vocational | 1 | 2007 | 3 | 0.070 |
Why?
| | Brain Mapping | 2 | 2025 | 536 | 0.070 |
Why?
| | Dominance, Cerebral | 1 | 2007 | 56 | 0.070 |
Why?
| | Amino Acid Motifs | 2 | 2019 | 224 | 0.070 |
Why?
| | Coronavirus 229E, Human | 1 | 2007 | 7 | 0.070 |
Why?
| | Recurrence | 2 | 2022 | 1135 | 0.060 |
Why?
| | Temporal Lobe | 1 | 2007 | 104 | 0.060 |
Why?
| | Atrophy | 1 | 2007 | 201 | 0.060 |
Why?
| | Morocco | 2 | 2017 | 3 | 0.060 |
Why?
| | Russia | 3 | 2017 | 13 | 0.060 |
Why?
| | Ecosystem | 2 | 2022 | 589 | 0.060 |
Why?
| | Bacteria | 2 | 2025 | 889 | 0.060 |
Why?
| | Science | 1 | 2007 | 56 | 0.060 |
Why?
| | Anxiety | 1 | 2014 | 1109 | 0.060 |
Why?
| | Cats | 1 | 2007 | 228 | 0.060 |
Why?
| | Memory Disorders | 1 | 2007 | 193 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2014 | 3604 | 0.060 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2025 | 5 | 0.060 |
Why?
| | Haplorhini | 2 | 2016 | 52 | 0.060 |
Why?
| | Vaccines, Synthetic | 2 | 2020 | 138 | 0.060 |
Why?
| | Hexosyltransferases | 1 | 2025 | 6 | 0.060 |
Why?
| | Immunocompetence | 1 | 2026 | 47 | 0.060 |
Why?
| | Jurkat Cells | 1 | 2006 | 114 | 0.060 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2025 | 17 | 0.060 |
Why?
| | Pyrimidines | 2 | 2020 | 532 | 0.060 |
Why?
| | Administration, Intranasal | 1 | 2026 | 93 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2608 | 0.060 |
Why?
| | Alpha Rhythm | 1 | 2025 | 11 | 0.060 |
Why?
| | Vesiculovirus | 1 | 2025 | 17 | 0.060 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2025 | 35 | 0.060 |
Why?
| | CD4 Antigens | 1 | 2026 | 139 | 0.060 |
Why?
| | Comprehension | 1 | 2007 | 180 | 0.060 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2017 | 157 | 0.060 |
Why?
| | Ecological Momentary Assessment | 1 | 2026 | 45 | 0.060 |
Why?
| | Research Personnel | 1 | 2007 | 186 | 0.060 |
Why?
| | Chickens | 2 | 2016 | 191 | 0.060 |
Why?
| | Gene Knockout Techniques | 1 | 2025 | 116 | 0.060 |
Why?
| | Hospitalization | 1 | 2015 | 2433 | 0.060 |
Why?
| | Peptides | 1 | 2011 | 995 | 0.060 |
Why?
| | Coronaviridae | 1 | 2024 | 4 | 0.060 |
Why?
| | Ribonucleoproteins | 2 | 2019 | 103 | 0.050 |
Why?
| | Phylogeography | 2 | 2015 | 55 | 0.050 |
Why?
| | Caregivers | 1 | 2014 | 1049 | 0.050 |
Why?
| | Leukemia Virus, Murine | 1 | 2004 | 17 | 0.050 |
Why?
| | Gray Matter | 1 | 2025 | 91 | 0.050 |
Why?
| | Immunogenicity, Vaccine | 1 | 2024 | 36 | 0.050 |
Why?
| | Chikungunya virus | 1 | 2025 | 86 | 0.050 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1266 | 0.050 |
Why?
| | Administration, Inhalation | 2 | 2016 | 574 | 0.050 |
Why?
| | Fibrillin-2 | 1 | 2024 | 2 | 0.050 |
Why?
| | Astrocytes | 1 | 2026 | 222 | 0.050 |
Why?
| | Virus Integration | 1 | 2024 | 69 | 0.050 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2024 | 48 | 0.050 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2004 | 92 | 0.050 |
Why?
| | Attention | 1 | 2007 | 457 | 0.050 |
Why?
| | Immunity, Cellular | 2 | 2018 | 272 | 0.050 |
Why?
| | Heart | 2 | 2018 | 636 | 0.050 |
Why?
| | Pollination | 1 | 2024 | 25 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 222 | 0.050 |
Why?
| | Microglia | 1 | 2026 | 268 | 0.050 |
Why?
| | Antibody Formation | 1 | 2024 | 294 | 0.050 |
Why?
| | Crystallography, X-Ray | 1 | 2025 | 492 | 0.050 |
Why?
| | Disease Progression | 2 | 2023 | 2847 | 0.050 |
Why?
| | Canada | 1 | 2024 | 428 | 0.050 |
Why?
| | Anhedonia | 1 | 2023 | 17 | 0.050 |
Why?
| | Fruit | 1 | 2024 | 152 | 0.050 |
Why?
| | Anesthesia | 2 | 2016 | 258 | 0.050 |
Why?
| | Ecology | 1 | 2024 | 121 | 0.050 |
Why?
| | Glycosylation | 2 | 2016 | 172 | 0.050 |
Why?
| | Carbon Cycle | 1 | 2022 | 14 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2006 | 419 | 0.050 |
Why?
| | Livestock | 1 | 2022 | 11 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2016 | 1306 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3409 | 0.040 |
Why?
| | Switzerland | 1 | 2021 | 46 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2022 | 164 | 0.040 |
Why?
| | Fresh Water | 1 | 2021 | 56 | 0.040 |
Why?
| | Pupa | 1 | 2021 | 14 | 0.040 |
Why?
| | Inpatients | 1 | 2026 | 545 | 0.040 |
Why?
| | Protein Subunits | 1 | 2022 | 226 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2016 | 1253 | 0.040 |
Why?
| | Argentina | 1 | 2020 | 30 | 0.040 |
Why?
| | Marsupialia | 1 | 2020 | 8 | 0.040 |
Why?
| | Rats | 2 | 2007 | 5597 | 0.040 |
Why?
| | Equidae | 1 | 2020 | 7 | 0.040 |
Why?
| | Chromogenic Compounds | 1 | 2020 | 4 | 0.040 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2020 | 20 | 0.040 |
Why?
| | Republic of Korea | 1 | 2020 | 42 | 0.040 |
Why?
| | Writing | 1 | 2022 | 100 | 0.040 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 16 | 0.040 |
Why?
| | Prepulse Inhibition | 1 | 2020 | 12 | 0.040 |
Why?
| | Membrane Fusion | 1 | 2020 | 40 | 0.040 |
Why?
| | Geographic Mapping | 1 | 2020 | 29 | 0.040 |
Why?
| | Biomarkers | 2 | 2023 | 4271 | 0.040 |
Why?
| | Genome Size | 1 | 2020 | 11 | 0.040 |
Why?
| | Yugoslavia | 1 | 2020 | 4 | 0.040 |
Why?
| | Ferrets | 1 | 2020 | 31 | 0.040 |
Why?
| | Cues | 1 | 2023 | 326 | 0.040 |
Why?
| | Blotting, Western | 2 | 2014 | 1187 | 0.040 |
Why?
| | Rubella | 1 | 2020 | 22 | 0.040 |
Why?
| | Tissue Fixation | 1 | 2020 | 36 | 0.040 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2020 | 35 | 0.040 |
Why?
| | Psychotropic Drugs | 1 | 2021 | 77 | 0.040 |
Why?
| | Apoptosis | 2 | 2019 | 2430 | 0.040 |
Why?
| | Paraffin Embedding | 1 | 2020 | 32 | 0.040 |
Why?
| | Pathology, Molecular | 1 | 2020 | 25 | 0.040 |
Why?
| | Blood Chemical Analysis | 1 | 2020 | 109 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2021 | 112 | 0.040 |
Why?
| | Formaldehyde | 1 | 2020 | 66 | 0.040 |
Why?
| | Transaminases | 1 | 2020 | 22 | 0.040 |
Why?
| | Diatoms | 1 | 2020 | 29 | 0.040 |
Why?
| | Phosphorylation | 2 | 2014 | 1732 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 149 | 0.040 |
Why?
| | Fertility | 1 | 2021 | 168 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2020 | 164 | 0.040 |
Why?
| | Junin virus | 1 | 2019 | 1 | 0.040 |
Why?
| | Codon | 1 | 2020 | 94 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 2019 | 37 | 0.040 |
Why?
| | Haplotypes | 1 | 2021 | 490 | 0.040 |
Why?
| | Reptiles | 1 | 2019 | 5 | 0.040 |
Why?
| | Electron Transport Complex III | 1 | 2019 | 18 | 0.040 |
Why?
| | HeLa Cells | 2 | 2012 | 650 | 0.040 |
Why?
| | Antigens, Viral | 1 | 2020 | 182 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 2019 | 6 | 0.040 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2020 | 175 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2021 | 342 | 0.040 |
Why?
| | Convalescence | 1 | 2019 | 19 | 0.040 |
Why?
| | Erythrocebus | 1 | 2019 | 1 | 0.040 |
Why?
| | Postoperative Period | 1 | 2020 | 354 | 0.040 |
Why?
| | Asia, Western | 1 | 2019 | 5 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2021 | 236 | 0.040 |
Why?
| | U937 Cells | 1 | 2018 | 27 | 0.040 |
Why?
| | Endothelium, Vascular | 2 | 2019 | 965 | 0.040 |
Why?
| | Analgesics | 1 | 2021 | 228 | 0.040 |
Why?
| | Viral Matrix Proteins | 1 | 2018 | 29 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2021 | 601 | 0.040 |
Why?
| | Fishes | 1 | 2019 | 108 | 0.040 |
Why?
| | Cyclin D1 | 1 | 2018 | 61 | 0.040 |
Why?
| | Sertoli Cells | 1 | 2018 | 28 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2006 | 1499 | 0.040 |
Why?
| | Transfection | 2 | 2011 | 940 | 0.040 |
Why?
| | Anesthetics, Dissociative | 1 | 2018 | 46 | 0.030 |
Why?
| | Acute Disease | 1 | 2021 | 1030 | 0.030 |
Why?
| | Purines | 1 | 2019 | 187 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 141 | 0.030 |
Why?
| | Metagenome | 1 | 2019 | 149 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2019 | 215 | 0.030 |
Why?
| | Endocrine Glands | 1 | 2018 | 14 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2026 | 2947 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 570 | 0.030 |
Why?
| | Ethanol | 1 | 2023 | 627 | 0.030 |
Why?
| | Peripheral Nervous System | 1 | 2018 | 20 | 0.030 |
Why?
| | Tight Junctions | 1 | 2018 | 81 | 0.030 |
Why?
| | Sf9 Cells | 1 | 2017 | 11 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 240 | 0.030 |
Why?
| | Spodoptera | 1 | 2017 | 40 | 0.030 |
Why?
| | Genitalia | 1 | 2018 | 34 | 0.030 |
Why?
| | Transcription Factors | 1 | 2006 | 1741 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11787 | 0.030 |
Why?
| | RNA Editing | 1 | 2017 | 26 | 0.030 |
Why?
| | Machine Learning | 1 | 2023 | 585 | 0.030 |
Why?
| | Epididymis | 1 | 2017 | 14 | 0.030 |
Why?
| | Exosomes | 1 | 2018 | 104 | 0.030 |
Why?
| | Autopsy | 1 | 2017 | 94 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2018 | 248 | 0.030 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1496 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2018 | 4154 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 123 | 0.030 |
Why?
| | Poultry | 1 | 2017 | 11 | 0.030 |
Why?
| | Sex Ratio | 1 | 2017 | 16 | 0.030 |
Why?
| | Drug Combinations | 1 | 2018 | 390 | 0.030 |
Why?
| | Databases, Factual | 1 | 2023 | 1486 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 177 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1047 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1886 | 0.030 |
Why?
| | Blotting, Northern | 1 | 2017 | 204 | 0.030 |
Why?
| | Neurons | 1 | 2026 | 1640 | 0.030 |
Why?
| | Air Movements | 1 | 2016 | 10 | 0.030 |
Why?
| | Medical Waste Disposal | 1 | 2016 | 3 | 0.030 |
Why?
| | HSC70 Heat-Shock Proteins | 1 | 2016 | 4 | 0.030 |
Why?
| | Laboratory Personnel | 1 | 2016 | 4 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 358 | 0.030 |
Why?
| | Climate | 1 | 2017 | 89 | 0.030 |
Why?
| | Environment, Controlled | 1 | 2016 | 23 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 2016 | 35 | 0.030 |
Why?
| | Vitreous Body | 1 | 2017 | 117 | 0.030 |
Why?
| | Animal Welfare | 1 | 2016 | 18 | 0.030 |
Why?
| | Nanopores | 1 | 2016 | 10 | 0.030 |
Why?
| | Microscopy | 1 | 2018 | 156 | 0.030 |
Why?
| | Nucleotide Motifs | 1 | 2016 | 36 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 779 | 0.030 |
Why?
| | Diamines | 1 | 2016 | 5 | 0.030 |
Why?
| | Geography | 1 | 2017 | 203 | 0.030 |
Why?
| | Lentivirus | 1 | 2016 | 60 | 0.030 |
Why?
| | Polysaccharides | 1 | 2016 | 87 | 0.030 |
Why?
| | trans-Golgi Network | 1 | 2016 | 15 | 0.030 |
Why?
| | Antibody-Dependent Enhancement | 1 | 2016 | 2 | 0.030 |
Why?
| | General Practice | 1 | 2016 | 32 | 0.030 |
Why?
| | Epidemics | 1 | 2017 | 98 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 946 | 0.030 |
Why?
| | Tidal Volume | 1 | 2016 | 111 | 0.030 |
Why?
| | Genetic Vectors | 1 | 2017 | 337 | 0.030 |
Why?
| | Benzothiazoles | 1 | 2016 | 40 | 0.030 |
Why?
| | Apathy | 1 | 2016 | 8 | 0.030 |
Why?
| | Travel | 1 | 2017 | 136 | 0.030 |
Why?
| | RNA, Satellite | 1 | 2015 | 1 | 0.030 |
Why?
| | Academies and Institutes | 1 | 2016 | 60 | 0.030 |
Why?
| | Coitus | 1 | 2015 | 23 | 0.030 |
Why?
| | Serogroup | 1 | 2015 | 44 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 389 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2016 | 133 | 0.030 |
Why?
| | Cortical Synchronization | 1 | 2015 | 12 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2022 | 917 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 869 | 0.030 |
Why?
| | Unsafe Sex | 1 | 2015 | 61 | 0.030 |
Why?
| | Medication Adherence | 1 | 2019 | 539 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 975 | 0.030 |
Why?
| | Organic Chemicals | 1 | 2016 | 127 | 0.030 |
Why?
| | Motivation | 1 | 2019 | 610 | 0.030 |
Why?
| | Topography, Medical | 1 | 2014 | 11 | 0.030 |
Why?
| | Quinolines | 1 | 2016 | 193 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 854 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1266 | 0.030 |
Why?
| | Protein Transport | 1 | 2016 | 441 | 0.030 |
Why?
| | Heart Rate | 1 | 2018 | 855 | 0.030 |
Why?
| | Psychological Tests | 1 | 2015 | 132 | 0.030 |
Why?
| | Drug Resistance, Viral | 1 | 2015 | 122 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1490 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 5960 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 173 | 0.030 |
Why?
| | Acari | 1 | 2013 | 2 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1257 | 0.030 |
Why?
| | Photic Stimulation | 1 | 2015 | 264 | 0.030 |
Why?
| | Signal Transduction | 2 | 2019 | 5226 | 0.030 |
Why?
| | Neurologic Examination | 1 | 2014 | 131 | 0.030 |
Why?
| | Actins | 1 | 2016 | 425 | 0.030 |
Why?
| | Hantaan virus | 1 | 2013 | 1 | 0.020 |
Why?
| | La Crosse virus | 1 | 2013 | 4 | 0.020 |
Why?
| | rab5 GTP-Binding Proteins | 1 | 2013 | 10 | 0.020 |
Why?
| | Adaptor Protein Complex 2 | 1 | 2013 | 11 | 0.020 |
Why?
| | Regression Analysis | 1 | 2016 | 1003 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2014 | 140 | 0.020 |
Why?
| | Chronic Disease | 1 | 2019 | 1813 | 0.020 |
Why?
| | Phenotype | 1 | 2021 | 3162 | 0.020 |
Why?
| | Diagnostic Tests, Routine | 1 | 2014 | 108 | 0.020 |
Why?
| | Cercopithecus | 1 | 2012 | 3 | 0.020 |
Why?
| | Mood Disorders | 1 | 2014 | 140 | 0.020 |
Why?
| | rab GTP-Binding Proteins | 1 | 2013 | 76 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 340 | 0.020 |
Why?
| | Vaccines, Virosome | 1 | 2012 | 1 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1370 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2013 | 197 | 0.020 |
Why?
| | Survival Analysis | 1 | 2015 | 1382 | 0.020 |
Why?
| | Genetic Markers | 1 | 2012 | 331 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2013 | 561 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 117 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 459 | 0.020 |
Why?
| | Risk Factors | 1 | 2026 | 10779 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4282 | 0.020 |
Why?
| | Social Behavior | 1 | 2014 | 288 | 0.020 |
Why?
| | Middle East | 1 | 2011 | 18 | 0.020 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 25 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1985 | 0.020 |
Why?
| | Small Molecule Libraries | 1 | 2012 | 111 | 0.020 |
Why?
| | Cytokines | 1 | 2019 | 2061 | 0.020 |
Why?
| | Bone Marrow Stromal Antigen 2 | 1 | 2010 | 11 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 341 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1356 | 0.020 |
Why?
| | Research Design | 1 | 2017 | 1135 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2012 | 175 | 0.020 |
Why?
| | GPI-Linked Proteins | 1 | 2010 | 80 | 0.020 |
Why?
| | Europe | 1 | 2011 | 412 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 612 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 538 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2010 | 336 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5992 | 0.020 |
Why?
| | Iron Metabolism Disorders | 1 | 2008 | 6 | 0.020 |
Why?
| | Structural Homology, Protein | 1 | 2008 | 23 | 0.020 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2008 | 15 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 116 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2009 | 304 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3671 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2832 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2878 | 0.020 |
Why?
| | Tyrosine | 1 | 2008 | 222 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1173 | 0.020 |
Why?
| | Emigration and Immigration | 1 | 2007 | 66 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 161 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 551 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2925 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2009 | 750 | 0.010 |
Why?
| | Viverridae | 1 | 2005 | 1 | 0.010 |
Why?
| | Antibodies | 1 | 2007 | 401 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1782 | 0.010 |
Why?
| | Iron | 1 | 2007 | 359 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2005 | 232 | 0.010 |
Why?
| | Incidence | 1 | 2011 | 2879 | 0.010 |
Why?
| | Asia, Central | 1 | 2003 | 1 | 0.010 |
Why?
|
|
Kuhn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|